Skeletal muscle proteins oxidation in chronic right heart failure in rats: Can different beta-blockers prevent it to the same degree?

International Journal of Cardiology

Volumn 143, Issue 2, 2010, Pages 192-199

  Libera, Luciano Dalla ^a   Ravara, Barbara ^a   Gobbo, Valerio ^a   Betto, Daniela Danieli ^a   Germinario, Elena ^a   Angelini, Annalisa ^a   Evangelista, Stefano ^b   Vescovo, Giorgio ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b Menarini Ricerche SpA   (Italy)

^c SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Cytokines; Oxidative stress; Oxyblot; Skeletal muscle

Indexed keywords

BISOPROLOL; ISOPROTEIN; MUSCLE PROTEIN; NEBIVOLOL; NITRIC OXIDE; SPHINGOSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HEART FAILURE; HEART PROTECTION; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE HYPERTROPHY; MALE; MUSCLE ATROPHY; MUSCLE RELAXATION; MUSCLE TWITCH; NICK END LABELING; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; SARCOMERE; SOLEUS MUSCLE; VASODILATATION;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; APOPTOSIS; BENZOPYRANS; BISOPROLOL; CHRONIC DISEASE; ETHANOLAMINES; HEART FAILURE; HYPERTROPHY, RIGHT VENTRICULAR; MALE; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SARCOMERES;

EID: 77956057285     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.02.012     Document Type: Article

References (38)

1. A.J.S. Coats, A.L. Clark, M. Piepoli, M. Volterrani, and P.A. Poole-Wilson Symptoms and quality of life in heart failure. The muscle hypothesis Br Heart J 72 1994 36 39
2. G. Vescovo, L. Dalla Libera, and F. Serafini Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition Circulation 98 1998 1742 1749
3. L. Dalla Libera, B. Ravara, and M. Volterrani Beneficial effects of Gh/IGF-1 on skeletal muscle atrophy and function in experimental heart failure Am J Physiol Cell Physiol 286 2004 C138 C144
4. G.S. Filippatos, C. Kanatselos, and D.D. Manolatos Studies on apoptosis and fibrosis in skeletal musculature: a comparison of heart failure patients with and without cardiac cachexia Int J Cardiol 90 2003 107 113
5. D. Mann, and M. Reid Exercise training and skeletal muscle inflammation in chronic heart failure: feeling better about fatigue J Am Coll Cardiol 42 2003 869 872
6. Lapu-Bula, and E. Ofili From hypertension to heart failure: role of nitric oxide-mediated endothelial dysfunction and emerging insights from myocardial contrast echocardiography Am J Cardiol 26 2007 7 14
7. L. Dalla Libera, B. Ravara, and V. Gobbo Skeletal muscle myofibrillar protein oxidation in heart failure and the protective effect of carvedilol J Mol Cell Cardiol 38 2005 803 807
8. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 Eur Heart J 29 2008 2388 2442
9. M. Packer Do beta-blockers prolong survival in heart failure only by inhibiting the beta1-receptor? A perspective on the results of the COMET trial J Card Fail 9 2003 429 443
10. M.D. Flather, M.C. Shibata, and A.J. Coats Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) Eur Heart J 26 2005 215 225
11. M. Blanchet, A. Ducharme, and N. Racine Effects of cold exposure on submaximal exercise performance and adrenergic activation in patients with congestive heart failure and the effects of beta-adrenergic blockade (carvedilol or metoptolol) Am J Cardiol 92 2003 548 553
12. A.P. Bolger, and F. Al-Nassser Beta-blockers for chronic heart failure: surviving long but feeling better? Int J Cardiol 92 2003 1 8
13. P. Dubach, J. Myers, and P. Bonetti Effects of bisoprolol fumarate on left ventricular size, function, and exercise capacity in patients with heart failure: analysis with magnetic resonance myocardial tagging Am Heart J 143 2002 676 683
14. M. Metra, M. Nardi, R. Giubbini, and L. Dei Cas Effects of short and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy J Am Coll Cardiol 24 1994 1678 1687
15. E. Agabiti Rosei, and D. Rizzoni Metabolic profile of nebivolol, a beta-adrenoceptor antagonist with unique characteristics Drugs 67 2007 1097 1107
16. G. Vescovo, C. Ceconi, and P. Bernocchi Skeletal muscle myosin heavy chain expression in rats with monocrotaline-induced cardiac hypertrophy and failure. Relation to blood flow and degree of muscle atrophy Cardiovasc Res 39 1998 233 241
17. K. Stoschitzky, G. Stoschitzky, H. Brussee, C. Bonelli, and H. Dobnig Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol Cardiology 106 2006 199 206
18. M. Canton, I. Neverova, R. Menabò, J. Van Eyk, and F. Di Lisa Evidence of myofibrillar protein oxidation induced by post-ischemic reperfusion in isolated rat hearts Am J Physiol Heart Circ Physiol 286 2004 H870 H877
19. L. Dalla Libera, B. Ravara, and A. Angelini Beneficial effects on skeletal muscle of the angiotensin II type I receptor blocker irbesartan in experimental heart failure Circulation 103 2001 2195 2200
20. L. Cuoco, G. Vescovo, and R. Castaman Skeletal muscle wastage in Crohn's disease: a pathway shared with heart failure? Int J. Cardiol 127 2008 219 227
21. G. Vescovo, M. Volterrani, and R. Zennaro Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes Heart 84 2000 431 437
22. L. Dalla Libera, R. Sabbadini, and C. Renken Apoptosis in the skeletal muscle of rats with heart failure is associated with increased serum levels of TNFa and sphingosine J Mol Cell Cardiol 33 2001 1871 1878
23. M. Midrio, D. Danieli Betto, A. Megighian, and R. Betto Early effects of denervation on sarcoplasmic reticulum properties of slow-twitch rat muscle fibers Pflugers Arch 434 1997 398 405
24. M. Sandri, C. Sandri, and A. Gilbert FOXO transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy Cell 117 2004 399 412
25. G. Vescovo, B. Ravara, V. Gobbo, A. Angelini, and L. Dalla Libera Skeletal muscle fibres synthesis in heart failure: role of PGC-1α, calcineurin and GH Int J Cardiol 104 2005 298 306
26. G. Vescovo, and L. Dalla Libera Skeletal muscle apoptosis in experimental heart failure: the only link between inflammation and skeletal muscle wastage? Curr Opin Clin Nutr Metab Care 9 2006 416 422
27. G. Vescovo, B. Ravara, and L. Dalla Libera Skeletal muscle myofibrillar protein oxidation and exercise capacity in heart failure Bas Res Cardiol 103 2008 285 290
28. S. Gielen, V. Adams, and S. Mobius-Winkler Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure J Am Coll Cardiol 42 2003 861 868
29. H. Tsutsui, T. Ide, and S. Hayashidani Enhanced generation of reactive oxygen species in the limb skeletal muscles from a murine infarct model of heart failure Circulation 104 2001 134 136
30. K. Nakamura, K. Kusano, and Y. Nakamura Carvedilol decreases elevated oxidative stress in human failing myocardium Circulation 105 2002 2867 2871
31. J.S. Chamberlein Cachexia in cancer zeroing in on myosin N Engl J Med 351 2004 2124 2125
32. P.C. Schulze, J. Fang, and K.A. Kassik Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction Circ Res 97 2005 418 426
33. R. Mason, R. Kubant, R.F. Jacob, M.F. JWalter, B. Boychuck, and T. Malinski Effect of nebivolol on endothelial nitric oxide and peroxynitrite release in hypertensive animals: role of antioxidant acrivity J Cardiovasc Pharmacol 48 2006 862 869
34. L.J. Ignarro Experimental evidences of nitric oxide-dependent vasodilatory activity of nebivolol, a third-generation β-blocker Blood Pressure 13 Suppl. 1 2004 2 16
35. V. Adams, U. Spate, and N. Krankel Nuclear factor-kappa B activation in skeletal muscle of patients with chronic heart failure: correlation with the expression of inducible nitric oxide synthase Eur J Cardiovasc Prev Rehabil 10 2003 273 277
36. V. Adams, B. Nehrhoff, and U. Spate Induction of iNOS expression in skeletal muscle by IL-1beta and NFkappaB activation: an in vitro and in vivo study Cardiovasc Res 54 2002 95 104
37. P.A. Poole-Wilson Commentary on the Carvedilol or Metoprolol European Trial (COMET) Am J Cardiol 6 2004 93
38. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150